Demystifying Moderna: Insights From 16 Analyst Reviews
Latest Ratings for MRNA Date Firm Action From To Mar 2022 Deutsche Bank Maintains Hold Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 SVB Leerink Maintains Underperform View More Analyst Ratings for MRNA View the Latest Analyst Ratings read more Latest Ratings for MRNA DateFirmActionFromTo Mar 2022Deutsche BankMaintainsHold Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022SVB LeerinkMaintainsUnderperform